European Journal of Oncology Pharmacy : Impact Factor & More
pISSN: 1783-3914
Share this on:
Key Metrics
CiteScore 
1
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
European Journal of Oncology Pharmacy Journal Specifications
Indexed in the following public directories
Scopus
| Overview | |
| Publisher | Pharma Publishing and Media Europe |
Planning to publish in European Journal of Oncology Pharmacy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in European Journal of Oncology Pharmacy
Cleaning validation of different cleaning procedures for monoclonal antibodies on stainless steel
- 1 Jan 2026
- European Journal of Oncology Pharmacy
Evaluation of long-term prevention of microbiological contamination of sterile preparations in a controlled ISO class 5 environment and an uncontrolled environment using a closed-system drug transfer device
- 1 Jan 2025
- European Journal of Oncology Pharmacy
Cost Evaluation of Subcutaneous Trastuzumab Versus Intravenous Trastuzumab for the Treatment of HER2-Positive Breast Cancer: Insights From Oncology Hospitals in Morocco
- 1 Jul 2024
- European Journal of Oncology Pharmacy
A pilot study of South African oncology pharmacy facilities: Comparison with best practice guidelines
- 1 Jul 2024
- European Journal of Oncology Pharmacy
Dinutuximab-beta after autologous peripheral blood stem cell transplantation improved event-free survival of newly diagnosed children with high-risk neuroblastoma but overall survival remains unchanged: Saudi Arabia's multi-institutional experiences
- 1 Jul 2024
- European Journal of Oncology Pharmacy
SFPO and ESOP recommendations for the practical stability of anticancer drugs: second update
- 1 Jul 2024
- European Journal of Oncology Pharmacy
Cleaning validation of different cleaning procedures for monoclonal antibodies on stainless steel
- 1 Jan 2026
- European Journal of Oncology Pharmacy
Evaluation of long-term prevention of microbiological contamination of sterile preparations in a controlled ISO class 5 environment and an uncontrolled environment using a closed-system drug transfer device
- 1 Jan 2025
- European Journal of Oncology Pharmacy
Cost Evaluation of Subcutaneous Trastuzumab Versus Intravenous Trastuzumab for the Treatment of HER2-Positive Breast Cancer: Insights From Oncology Hospitals in Morocco
- 1 Jul 2024
- European Journal of Oncology Pharmacy
A pilot study of South African oncology pharmacy facilities: Comparison with best practice guidelines
- 1 Jul 2024
- European Journal of Oncology Pharmacy
Dinutuximab-beta after autologous peripheral blood stem cell transplantation improved event-free survival of newly diagnosed children with high-risk neuroblastoma but overall survival remains unchanged: Saudi Arabia's multi-institutional experiences
- 1 Jul 2024
- European Journal of Oncology Pharmacy
SFPO and ESOP recommendations for the practical stability of anticancer drugs: second update
- 1 Jul 2024
- European Journal of Oncology Pharmacy
FAQs on European Journal of Oncology Pharmacy
How many articles did European Journal of Oncology Pharmacy publish last year? 
What is Citescore for European Journal of Oncology Pharmacy?
Who is the publisher of European Journal of Oncology Pharmacy?
